Literature DB >> 10985794

Two distinct regions of the yeast mitochondrial ADP/ATP carrier are photolabeled by a new ADP analogue: 2-azido-3'-O-naphthoyl-[beta-32P]ADP. Identification of the binding segments by mass spectrometry.

A C Dianoux1, F Noël, C Fiore, V Trézéguet, S Kieffer, M Jaquinod, G J Lauquin, G Brandolin.   

Abstract

A novel photoactivatable radioactive ADP derivative, namely, 2-azido-3'-O-naphthoyl-[beta-(32)P]ADP (2-azido-N-[(32)P]ADP), was synthesized with the aim at mapping the substrate binding site(s) of the yeast mitochondrial ADP/ATP carrier. It was used with mitochondria isolated from genetically modified strains of Saccharomyces cerevisiae, producing the native or the His-tagged Anc2p isoform of the carrier. In darkness, 2-azido-N-[(32)P]ADP was reversibly bound to the carrier in mitochondria, without being transported. Upon photoirradiation, only the ADP/ATP carrier was covalently radiolabeled among all mitochondrial proteins. Specificity of labeling was demonstrated since carboxyatractyloside (CATR), a potent inhibitor of ADP/ATP transport, totally prevented the incorporation of the photoprobe. To localize the radioactive region(s), the purified photolabeled carrier was submitted to CNBr or hydroxylamine cleavage. The resulting fragments were characterized and identified by SDS-PAGE, Western blotting, amino acid sequencing, and MALDI-MS and ESI-MS analyses. Two short photolabeled distinct segments, eight and nine residues long, were identified: S183-R191, located in the central part of the ADP/ATP carrier; and I311-K318, belonging to its C-terminal end. Plausible models of organization of the nucleotide binding site(s) of the carrier involving the two regions specifically labeled by 2-azido-N-[(32)P]ADP are proposed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10985794     DOI: 10.1021/bi000618l

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Structural and functional implications of the instability of the ADP/ATP transporter purified from mitochondria as revealed by FTIR spectroscopy.

Authors:  Víctor A Lórenz-Fonfría; Joaquim Villaverde; Véronique Trézéguet; Guy J-M Lauquin; Gérard Brandolin; Esteve Padrós
Journal:  Biophys J       Date:  2003-07       Impact factor: 4.033

2.  Modeling the transmembrane arrangement of the uncoupling protein UCP1 and topological considerations of the nucleotide-binding site.

Authors:  Amalia Ledesma; Mario García de Lacoba; Ignacio Arechaga; Eduardo Rial
Journal:  J Bioenerg Biomembr       Date:  2002-12       Impact factor: 2.945

3.  Yeast ADP/ATP carrier isoform 2: conformational dynamics and role of the RRRMMM signature sequence methionines.

Authors:  Benjamin Clémençon; Martial Rey; Véronique Trézéguet; Eric Forest; Ludovic Pelosi
Journal:  J Biol Chem       Date:  2011-08-25       Impact factor: 5.157

4.  Efficient identification of photolabelled amino acid residues by combining immunoaffinity purification with MS: revealing the semotiadil-binding site and its relevance to binding sites for myristates in domain III of human serum albumin.

Authors:  Kohichi Kawahara; Akihiko Kuniyasu; Katsuyoshi Masuda; Masaji Ishiguro; Hitoshi Nakayama
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

5.  Substrate binding in the mitochondrial ADP/ATP carrier is a step-wise process guiding the structural changes in the transport cycle.

Authors:  Vasiliki Mavridou; Martin S King; Sotiria Tavoulari; Jonathan J Ruprecht; Shane M Palmer; Edmund R S Kunji
Journal:  Nat Commun       Date:  2022-06-23       Impact factor: 17.694

6.  Four mutations in transmembrane domains of the mitochondrial ADP/ATP carrier increase resistance to bongkrekic acid.

Authors:  Igor Zeman; Christine Schwimmer; Vincent Postis; Gérard Brandolin; Claudine David; Véronique Trézéguet; Guy J M Lauquin
Journal:  J Bioenerg Biomembr       Date:  2003-06       Impact factor: 2.945

Review 7.  The mitochondrial ADP/ATP carrier: functional and structural studies in the route of elucidating pathophysiological aspects.

Authors:  Véronique Trézéguet; Ludovic Pélosi; Guy J M Lauquin; Gérard Brandolin
Journal:  J Bioenerg Biomembr       Date:  2008-11-01       Impact factor: 3.853

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.